Walgreens Boots Alliance (NASDAQ:WBA) Releases Earnings Results, Misses Estimates By $0.04 EPS

Walgreens Boots Alliance (NASDAQ:WBA) posted its earnings results on Thursday. The pharmacy operator reported $0.63 EPS for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.04), Briefing.com reports. The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period last year, the business earned $1.00 earnings per share. Walgreens Boots Alliance updated its FY 2024 guidance to 2.800-2.950 EPS and its FY24 guidance to $2.80-$2.95 EPS.

Walgreens Boots Alliance Price Performance

WBA opened at $12.19 on Friday. The company’s 50 day simple moving average is $16.72 and its 200 day simple moving average is $20.33. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance has a 1 year low of $11.68 and a 1 year high of $31.32. The stock has a market capitalization of $10.52 billion, a PE ratio of -1.74, a P/E/G ratio of 0.98 and a beta of 0.78.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were given a $0.25 dividend. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 8.20%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.29%.

Insider Buying and Selling

In related news, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The shares were purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Corporate insiders own 17.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on WBA shares. UBS Group decreased their price target on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a research note on Monday. Raymond James restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. SVB Leerink reduced their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Evercore ISI reduced their price objective on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating for the company in a research note on Monday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $23.07.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.